The Research & Innovation Committee at the IoPPN (KCL) organises annual conferences exploring novel methodological and translational approaches changing the face of neurobiological research from bench to bedside.

This year’s event “Neurotechnologies: Current Developments, Applications and Ethical Issues” showcased the potential of new neurotechnological inventions (ranging from stem cell therapies, over deep brain stimulation to AI and human-technology symbiosis) in diagnosis and treatment of neurological and psychiatric conditions. Our speakers, included keynotes by Professors Viviane Tabar, Ed Boyden and Dustin Tyler, also presented the cutting-edge methodological innovations revolutionising neurobiological research and discussed the ethical issues surrounding their application.

Chairs: Professor Mitul Mehta and Dr Marija Petrinovic

Tools for Analyzing and Repairing the Brain
Ed Boyden, Professor, Departments of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering Y. Eva Tan Professor in Neurotechnology, McGovern Institute and HHMI, USA

Parsing autism heterogeneity with cross-species fMRI
Alessandro Gozzi, Italian Institute of Technology, Rovereto, Italy

Renervate Therapeutics: Advancing treatments for spinal cord injury through the convergence of bioinspired materials and Synthetic Biology Abigail Conner University of Waterloo, ON, Canada
Stephanie Avraamides, University of Cambridge, UK

Human-Technology Symbiosis with Neurotechnologies: Create a Thriving, Just, and Connected World
Dustin Tyler, Kent H Smith Professor II of Biomedical Engineering Director, Human Fusions Institute (HFi) Case Western Reserve University; Associate Director, Cleveland Advanced Platform Technology Center Cleveland - Louis Stokes Dept. of Veterans Affairs Medical Center, USA